NASDAQ:RNAZ | Income Statement | Transcode Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$3.69M$6.79M-$6.79M$39,677.00-$6.75M-$6.75M-$7.17-$7.17957,191957,191
2026-03-31$5.11M$17.76M-$17.76M$201,267.00-$17.55M-$17.79M-$21.28-$21.28916,968916,968
2025-12-31$5.48M$16.03M-$16.03M$2.81M$226,069.00-$13.44M-$18.10-$18.1074,44974,449
2025-09-30$3.16M$4.56M-$4.56M-$294,851.00-$4.86M-$5.82-$5.82833,683833,683
2025-06-30$2.57M$4.22M-$4.22M-$55,368.00-$4.28M-$4.28M-$5.13-$5.13833,653833,653
2025-03-31$2.22M$3.17M-$3.17M-$8.91M-$12.09M$0.00-$12.09M-$70.16-$70.16172,262172,262
2024-12-31$3.64M$5.09M-$5.09M-$823,570.00$0.00-$5.92M-$218.74-$218.742,8622,862
2024-09-30$1.23M$2.17M-$2.17M-$155,975.00$0.00-$2.32M-$146.06-$146.0615,89315,893
2024-06-30$3.08M$5.11M-$5.11M-$76,898.00$0.00-$5.19M-$680.23-$680.237,6317,631
2024-03-31$1.76M$3.29M-$3.29M-$37,830.00$0.00-$3.33M-$21.35-$21.35155,831155,831
2023-12-31$3.36M$4.1M-$4.1M$10,041.00$0.00-$4.09M-$3,145.35-$3,145.35-47,410-47,410
2023-09-30$3.34M$5.31M-$5.31M$10,290.00$0.00-$5.3M-$48.44-$48.44109,413109,413
2023-06-30$2.97M$5.12M-$5.12M$781,340.00$0.00-$4.34M-$142.38-$142.3830,49430,494
2023-03-31$2.59M$4.89M-$4.89M$70,750.00$0.00-$4.82M-$259.07-$259.0718,59318,593
2022-12-31$2.69M$5.5M-$5.5M$361,417.00$0.00-$5.13M-$1,063.63-$1,063.63-632,640-632,640
2022-09-30$3.04M$4.95M-$4.95M$663,950.00$0.00-$4.29M-$6.61-$6.61648,862648,862
2022-06-30$2.62M$4.71M-$4.71M$36,061.00$0.00-$4.67M-$7.20-$7.20648,862648,862
2022-03-31$1.88M$3.48M-$3.48M$7,432.00$0.00-$3.47M-$0.27-$0.2712,977,23412,977,234
2021-12-31$1.29M$2.99M-$2.99M$186,975.00$53,051.00-$2.8M-$0.23-$0.231,492,8981,492,898
2021-09-30$992,946.00$2.36M-$2.36M$30,203.00$0.00-$2.33M-$0.20-$0.2011,526,51411,526,514
2021-06-30$211,752.00$355,528.00-$355,528.00$3.13M$2.77M$0.00$2.77M$0.60$0.514,636,2165,400,184
2021-03-31$263,759.00$449,465.00-$449,465.00-$4.04M$0.00-$4.49M-$0.97-$0.974,636,2164,636,216
2020-12-31$151,823.00$379,001.00-$379,001.00-$422,530.00$0.00-$801,531.00-$0.1800
2020-09-30$53,936.00$239,491.00-$239,491.00-$1.13M$0.00-$1.37M-$0.304,636,2164,636,216
2020-06-30$75,000.00$91,605.00-$91,605.00-$35,593.00-$127,198.00$0.00-$127,198.00-$0.03-$0.034,636,2164,636,216
2020-03-31-$41,260.00

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$13.42M$27.98M-$27.98M-$6.45M-$34.44M$226,069.00-$34.66M-$52.59-$52.59689,713689,713
2024-12-31$9.71M$15.66M-$15.66M-$1.09M-$16.75M$0.00-$16.75M-$1,336.63-$1,336.6312,55812,558
2023-12-31$12.26M$19.42M-$19.42M$872,421.00$0.00-$18.55M-$3,419.01-$3,419.015,4245,424
2022-12-31$10.23M$18.63M-$18.63M$1.07M$0.00-$17.56M-$1,082.79-$1,082.7916,22216,222
2021-12-31$2.75M$6.15M-$6.15M-$692,264.00$53,051.00-$6.84M-$0.81-$0.818,425,8808,425,880
2020-12-31$284,459.00$726,604.00-$726,604.00-$1.62M$0.00-$2.34M-$0.51-$0.514,636,2164,636,216